These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8908253)

  • 61. Immunohistochemical analysis of the cytokeratin expression in middle ear cholesteatoma and related epithelial tissues.
    Broekaert D; Coucke P; Leperque S; Ramaekers F; Van Muijen G; Boedts D; Leigh I; Lane B
    Ann Otol Rhinol Laryngol; 1992 Nov; 101(11):931-8. PubMed ID: 1280020
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cholesteatoma epithelium is characterized by increased expression of Ki-67, p53 and p21, with minimal apoptosis.
    Huisman MA; De Heer E; Grote JJ
    Acta Otolaryngol; 2003 Apr; 123(3):377-82. PubMed ID: 12737294
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Basement membrane in middle ear cholesteatoma. Immunohistochemical and ultrastructural observations.
    Sudhoff H; Bujía J; Borkowshi G; Koc C; Holly A; Hildmann H; Fisseler-Eckhoff A
    Ann Otol Rhinol Laryngol; 1996 Oct; 105(10):804-10. PubMed ID: 8865776
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Angiogenesis and angiogenic growth factors in middle ear cholesteatoma.
    Sudhoff H; Dazert S; Gonzales AM; Borkowski G; Park SY; Baird A; Hildmann H; Ryan AF
    Am J Otol; 2000 Nov; 21(6):793-8. PubMed ID: 11078065
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Expression of involucrin in human middle ear cholesteatoma.
    Chao WY; Huang CC
    Am J Otol; 1989 Sep; 10(5):385-8. PubMed ID: 2683803
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The effect of BMP-2, BMP-4 and BMP-6 on bone destruction of cholesteatoma presence.
    Oger M; Alpay HC; Orhan I; Onalan EE; Yanilmaz M; Sapmaz E
    Am J Otolaryngol; 2013; 34(6):652-7. PubMed ID: 23927997
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Expressions of TRPVs in the cholesteatoma epithelium.
    Do BH; Koizumi H; Ohbuchi T; Kawaguchi R; Suzuki H
    Acta Otolaryngol; 2017 Oct; 137(10):1039-1045. PubMed ID: 28599589
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Differential expression of human beta defensin 2 and human beta defensin 3 in human middle ear cholesteatoma.
    Song JJ; Chae SW; Woo JS; Lee HM; Jung HH; Hwang SJ
    Ann Otol Rhinol Laryngol; 2007 Mar; 116(3):235-40. PubMed ID: 17419529
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Epidermal differentiation in the human external auditory meatus.
    Vennix PP; Kuijpers W; Peters TA; Tonnaer EL; Ramaekers FC
    Laryngoscope; 1996 Apr; 106(4):470-5. PubMed ID: 8614223
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Cell adhesion proteins in external auditory canal cholesteatoma].
    Naim R; Riedel F; Bran G; Sadick H; Hörmann K
    HNO; 2004 Dec; 52(12):1083-7. PubMed ID: 15067413
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Expression of epidermal growth factor receptor in human middle ear cholesteatoma.
    Hsu YC; Ho KY; Chai CY; Lee KW; Wang LF; Wu SC; Kuo WR; Tsai SM
    Kaohsiung J Med Sci; 2003 Oct; 19(10):497-502. PubMed ID: 14620675
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Molecular control of bone resorption in chronic otitis media with cholesteatoma].
    Kuczkowski J; Kobierska-Gulida G; Izycka-Swieszewska E; Potocka M; Mikaszewski B; Sierszeń W
    Otolaryngol Pol; 2010; 64(4):219-24. PubMed ID: 20873097
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Apoptosis in the pathogenesis of cholesteatoma in adults.
    Olszewska E; Chodynicki S; Chyczewski L
    Eur Arch Otorhinolaryngol; 2006 May; 263(5):409-13. PubMed ID: 16378223
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Immunohistochemical basement membrane analysis of cholesteatoma epithelium].
    Lang S; Nerlich A; Wiest I; Schreiner M
    Laryngorhinootologie; 1994 Jul; 73(7):371-4. PubMed ID: 7916782
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Increased permeability of the epithelium of middle ear cholesteatoma.
    Koizumi H; Suzuki H; Ohbuchi T; Kitamura T; Hashida K; Nakamura M
    Clin Otolaryngol; 2015 Apr; 40(2):106-14. PubMed ID: 25319490
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Hyperproliferation-associated keratin expression in human middle ear cholesteatoma.
    Bujía J; Schilling V; Holly A; Stammberger M; Kastenbauer E
    Acta Otolaryngol; 1993 May; 113(3):364-8. PubMed ID: 7685977
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Expression of Apoptotic vs Antiapoptotic Proteins in Middle Ear Cholesteatoma.
    Chung JH; Lee SH; Park CW; Kim KR; Tae K; Kang SH; Oh YH; Pyo JY
    Otolaryngol Head Neck Surg; 2015 Dec; 153(6):1024-30. PubMed ID: 26124267
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Expression and significance of HIF-1alpha and iNOS in human middle ear cholesteatoma epithelium].
    Zhang E; Gong S
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 May; 21(10):463-5. PubMed ID: 17650819
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Possible role of transforming growth factor alpha on the cholesteatoma growth regulation].
    Xu Y; Wu Z; Tao Z; Hua Q; Jin K
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2003 Jan; 17(1):32-4. PubMed ID: 12725186
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Notch Signaling in Acquired Middle Ear Cholesteatoma.
    Fukuda A; Kano S; Nakamaru Y; Morita S; Hoshino K; Fujiwara K; Homma A
    Otol Neurotol; 2021 Oct; 42(9):e1389-e1395. PubMed ID: 34172659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.